<DOC>
	<DOC>NCT02102568</DOC>
	<brief_summary>Prospective multicenter study, Out Health Products that evaluates to 2 years the impact of chemo-induced menopause (MCI) on the functional score of quality of life questionnaire QLQ-C30 in young women age childbearing and living with breast cancer.</brief_summary>
	<brief_title>Study the Impact of Chemo-induced Menopause on the Quality of Life in Young Women of Childbearing Age and Diagnosed With Non-metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Patient aged over 18 and under 45 Patient without amenorrhea at diagnosis Performance status 2 (according to WHO criteria ) Patient diagnosed with histologically proven breast cancer , non metastatic Clinical Stages I , IIA , IIB and IIIA Positive Hormone Receptors (defined by a rate of 10% of labeled cells and immunohistochemistry (IHC) ) or negative Status HER2 positive or HER2 negative ( defined a score of 0 or 1 + by IHC , or a 2 + score by IHC and FISH / ISHS / CISH negative) Patients treated with neoadjuvant or adjuvant chemotherapy hematological, renal and hepatic functions satisfying : ANC&gt; 2,109 / L, platelets &gt; 100 . 109 / L, Hb&gt; 10 g / dl , normal bilirubin, AST and ALT &lt;2.5 upper normal value ( VNS) , alkaline phosphatase &lt;2.5 VSN , creatinine clearance &gt; 60 ml / min Obtaining informed consent in writing, signed and dated Affiliation Social Security system (or be the beneficiary of such a plan ) under the terms of the Act of August 9, 2004 Patient male Cancer metastatic Any tumor T4 ( skin invasion , deep grip, inflammatory breast cancer ) Patient who underwent surgical castration of ovariectomy type hysterectomy or tubal ligation Please have endometriosis Please pregnant or nursing Please not using effective contraception Patient who have had hormone therapy or chemotherapy Patient who have already taken similar Gn RH or LH RH (chemical castration) Patient whose mother was early menopause without treatment Presence of comorbidities related to fertility or medical history related to fertility ovarian failure types or sterility significant neurological or psychiatric abnormalities Inability of the patient to complete the questionnaires ( the language barrier ) Private Patient freedom by court or administrative Patient with another pathology deemed incompatible with the input of the patient in the protocol Participation in another clinical trial involving the chemical or surgical castration of the patient Please geographically unstable in the next 6 months or residing away from the treatment center and thereby making it difficult to monitor</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>